Endothelial Cell News Volume 7.23 | Jul 4 2022

    0
    25







    2022-07-04 | ENDOCN 7.23


    Endothelial Cell News by STEMCELL Technologies
    Vol. 7.23 – 4 July, 2022
    TOP STORY

    ALK1 Controls Hepatic Vessel Formation, Angiodiversity, and Angiocrine Functions in Hereditary Hemorrhagic Telangiectasia of the Liver

    In liver sinusoidal endothelial cells in vitro, stimulation or inhibition of ALK1 signaling counter-regulated Inhibitors of DNA binding 1-3, known Alk1 transcriptional targets.
    [Hepatology]

    Abstract

    ON1098-728 x 90
    PUBLICATIONSRanked by the impact factor of the journal

    Surface Micropatterning for the Formation of an In Vitro Functional Endothelial Model for Cell-Based Biosensors

    Surface adhesion micropatterns were used to control the adhesion of endothelial cells within adjacent hexagonal microstructures to promote the emergence of a well-controlled and standardized cell layer phenotype onto surface plasmon resonance sensor surfaces.
    [Biosensors & Bioelectronics]

    Abstract

    A Vascularized Model of the Human Liver Mimics Regenerative Responses

    Investigators found that exposing the endothelium-lined channel to fluid flow led to increased secretion of regeneration-associated factors.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    EPSTI1 Promotes Monocyte Adhesion to Endothelial Cells In Vitro via Upregulating VCAM-1 and ICAM-1 Expression

    Scientists investigated the role of epithelial-stromal interaction 1 (EPSTI1) in monocyte-endothelial cell adhesion and its expression pattern in atherosclerotic plaques.
    [Acta Pharmacologica Sinica]

    Abstract

    Aiphanol, a Multi-Targeting Stilbenolignan, Potently Suppresses Mouse Lymphangiogenesis and Lymphatic Metastasis

    The authors showed that aiphanol dose-dependently counteracted VEGF-C-induced proliferation, migration, and tubular formation of lymphatic endothelial cells, which was further verified in vivo.
    [Acta Pharmacologica Sinica]

    Abstract

    Functional Cargos of Exosomes Derived from Flk-1+ Vascular Progenitors Enable Neurulation and Ameliorate Embryonic Anomalies in Diabetic Pregnancy

    Researchers showed that progenitor exosomal communication across embryonic organs occured in normal development and was altered in embryos of diabetic pregnancy.
    [Communications Biology]

    Full Article

    Engineering Bioactive Nanoparticles to Rejuvenate Vascular Progenitor Cells

    Scientists reported a strategy to rejuvenate circulating vascular progenitor cells by conjugation of drug-loaded liposomal nanoparticles directly to the surface of gestational diabetes mellitus-exposed endothelial colony-forming cells.
    [Communications Biology]

    Full Article

    The Combination of Mesoglycan and VEGF Promotes Skin Wound Repair by Enhancing the Activation of Endothelial Cells and Fibroblasts and Their Cross-Talk

    Investigators found that the association between mesoglycan/VEGF had a strong pro-healing activity. In detail, this combination induced angiogenesis in human endothelial cells promoting in turn fibroblasts recruitment.
    [Scientific Reports]

    Full Article

    Integrated Proteomic Analysis to Explore the Molecular Regulation Mechanism of IL-33 mRNA Increased by Black Carbon in the Human Endothelial Cell Line EA.hy926

    Researchers identified that black carbon induced mitochondrial damage and suppressed autophagy function in EA.hy926 cells, as evidenced by elevation of the aspartate aminotransferase, reactive oxygen species, and p62, and the reduction of mitochondrial membrane potential.
    [Environmental Toxicology]

    Abstract

    ON1104SM-Small-Molecules-Wallchart-728x90
    REVIEWS

    Targeting Fibrosis, Mechanisms and Clinical Trials

    The authors summarize the abnormal cells — epithelial cells, endothelial cells, immune cells, and fibroblasts — and their interactions in fibrosis.
    [Signal Transduction and Targeted Therapy]

    Full Article

    INDUSTRY AND POLICY NEWS

    EYLEA® (Aflibercept) Injection sBLA for Every 16-Week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review

    Regeneron Pharmaceuticals, Inc. announced the US FDA has accepted for review the EYLEA® Injection supplemental Biologics License Application for an every 16-week 2 mg dosing regimen in patients with diabetic retinopathy.
    [Regeneron Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    Cell Bio 2022

    December 3 – 7, 2022
    Washington, DC, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellowship – iPSC-Derived Organoid/Gastruloid Development

    University of Oslo – Oslo, Norway

    Associate Professor – Cardiovascular Research

    The University of Tennessee Health Science Center – Memphis, Tennessee, United States

    Senior Research Assistant – Umbilical Vein Endothelial Cells

    University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Postdoctoral Position – Vascular Biology and Inflammation

    Aarhus University – Aarhus, Denmark

    Postdoctoral Scientist – Cardiovascular Systems

    University of California, San Diego – La Jolla, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Endothelial Cell News Twitter